AI Diagnostics Market Poised for 10x Growth by 2033 — Grand View Research, Inc.

Event summary

The global AI diagnostics market is projected to reach $9.7B by 2033, up from $2.4B in 2026, representing a 21.7% CAGR.
North America dominated the market with 54.8% revenue share in 2025, driven by advanced healthcare infrastructure and high adoption of digital health technologies.
Software solutions accounted for the largest component segment share at 46.2% in 2025, fueled by advancements in AI algorithms and cloud-based healthcare platforms.
Neurology represented the leading diagnosis segment with a 24.1% revenue share in 2025, supported by the increasing prevalence of neurological disorders.

The big picture

The AI diagnostics market is experiencing rapid growth due to the increasing demand for faster and more accurate disease detection. This trend is driven by advancements in machine learning and deep learning technologies, as well as the growing need for early intervention in chronic diseases. The market's expansion is further supported by strategic developments and innovations from key players focusing on product development and acquisitions.

What we're watching

Market Expansion: The pace at which AI diagnostics adoption accelerates in emerging markets like Asia Pacific, where healthcare digitization and rising patient populations are key growth drivers.
Technological Advancements: How continuous advancements in AI algorithms and machine learning technologies will further enhance diagnostic accuracy and efficiency across various medical applications.
Competitive Dynamics: Whether key players like Siemens Healthineers, Philips N.V., and GE Healthcare can sustain their market positions through strategic partnerships and technology advancements.